The RCVS statement, which can be read in full here, highlighted the fact that there is no body of evidence that homeopathy is effective and nor is it based on sound scientific principles. It should therefore be considered as complementary rather than alternative to treatments which are based on sound scientific principles, or for which there is a recognised evidence base.
In fact, the RCVS statement said nothing new. The principle that veterinary surgeons must first prescribe licensed medicines tested for safety and efficacy is enshrined in the Veterinary Medicines Regulations 2013, which say that if there is no veterinary medicine authorised in the United Kingdom for a condition in a particular species the veterinary surgeon responsible for the animal may treat with a veterinary medicine authorised for use in another animal species or for another condition in the same species, or, failing that, either a medicine authorised in the UK for human use, or a veterinary medicine authorised in another member state for use with any animal species in accordance with the Special Import Scheme, or a specially prepared (extemporaneous preparation or special) medicine, or exceptionally a medicine imported from outside the EU.
There are no homeopathic treatments listed by the VMD as 'authorised', just a handful of homeopathic preparations listed as 'registered', something which, as the BAHVS itself points out, means they have not been subjected to the same evaluation as authorised medicines or tested for efficacy.
The BAHVS is fond of using anecdote as evidence of efficacy (see the endorsements at the foot of this page: http://www.bahvs.com/), so one veterinary surgeon has been inviting colleagues to share their experiences of homeopathy causing harm on social media, in order to produce an infographic (pictured above right, click to enlarge) highlighting the very real harm caused when, for example, owners 'vaccinate' against parvo with homeopathic nosodes, only to have a dead litter on their hands.
The draft infographic can be found here.
The consultation, which was held by the College early in 2017, asked for the views of veterinary surgeons and nurses, animal owners, and stakeholders on the use of telemedicine in veterinary clinical practice.
The consultation was designed to help identify potential risks associated with telemedicine, identify areas where it may help address the needs of both clinicians and the public, and support the potential development of new professional standards and guidance.
The online survey of veterinary professionals received 1,230 responses, while the public consultation received 229 responses and the survey of organisations/stakeholders received eight responses.
The headline question asked of veterinary professionals was whether RCVS 'supporting guidance to the Code of Professional Conduct' should be amended to allow remote examination to take the place of physical examination in certain circumstances. 41% said 'Yes', 40% said 'No' and 18% were unsure.
Veterinary professionals and organisations were then asked a series of questions in order to establish how they rated the risk associated with telemedicine according to activity type, practice type, clinical sign or syndrome, mode of technology, and familiarity with client, animal or environment.
Unsurprisingly perhaps, the majority felt that providing just general advice presented a low risk. At the other end of the scale, most felt that the use of telemedicine to diagnose disease or injury would be either 'high risk', or 'not appropriate at all'.
Likewise, the majority said the risks would be low or medium where the client and environment were known and the animal seen before, for the same problem. By contrast, the majority said telemedicine would be either 'high risk' or 'not appropriate at all' when the client, animal and environment were all unknown.
When asked whether the current definition of 'under care' should be extended to allow veterinary surgeons to prescribe veterinary medicines where there has been no physical examination of the animal, 69% said 'No', 16% said 'Yes' and 15% were unsure.
However, when asked whether certain types of veterinary medicines should be able to be prescribed without a physical examination of the animal, the majority of respondents to the professional survey (52%) were in favour.
The results of the consultation were first considered at a special meeting of the Standards Committee in August 2017, where it was noted how the consultation had revealed significant confusion around current supporting guidance to the RCVS Code of Professional Conduct and that, at a minimum, clarification as to what was currently permissible was needed.
The Committee determined a key issue going forward was whether to change the Supporting Guidance to the RCVS Code of Professional Conduct regarding 'under care' to allow veterinary surgeons to prescribe POM-V medicines based on telemedicine alone.
Given the complex nature of the issues and the wide-ranging implications, the Standards Committee presented a range of options for amending RCVS Guidance to RCVS Council at its meeting in November 2017. After discussion, Council asked the Standards Committee to continue their review and to present more detailed proposals to Council regarding the future of telemedicine in clinical veterinary practice.
Anthony Roberts, RCVS Director of Leadership and Innovation, said: "We would like to thank all those who took the time to respond to the consultation – although Council has not yet made any firm decisions, we felt it would be useful to share our research so far.
"The use of telemedicine is growing rapidly in human healthcare and it is only right the RCVS assesses the opportunities it could bring to improve access to veterinary services. It is critical, however, that we understand the issues it presents 'at the coal face' and consider all the available evidence before making any changes to our Guidance. The RCVS should ensure its regulatory framework fosters innovation and maximises the opportunities to improve the quality, efficacy and accessibility of veterinary services, whilst at the same time protecting animal health and welfare."
The Standards Committee will meet again in April 2018 to take further evidence and develop proposals to take the issue forward.
Meanwhile, the full summary is available on the College’s website: www.rcvs.org.uk/telemeds-summary/.
There were two charges against Mr Staton, the first being that he failed to comply with eight requests from the RCVS sent by letter between November 2014 and August 2017 in relation to his continuing professional development (CPD) records.
The second charge was that between 1st January 2012 and 7th November 2017 he failed to have professional indemnity insurance or equivalent arrangements in place.
Mr Staton’s request to adjourn the hearing and agree undertakings was not opposed by the RCVS. The Committee had regard to advice of the Legal Assessor and submissions from both counsel for the RCVS and legal advisor for Mr Staton. In accepting Mr Staton’s request for adjournment and his undertakings no admissions have been made in respect of the charges against him.
In deciding whether to accept the adjournment and undertakings, the Committee was asked to consider a number of factors including Mr Staton’s age and health, his unblemished career of more than 50 years, the fact that he had closed his practice and retired from clinical practice on 31 March 2018 and that he had no intention of practising as a veterinary surgeon again. For those reasons the Committee felt it would be disproportionate to take Mr Staton through a full hearing.
Ian Green, chairing the Committee and speaking on its behalf, said: "In coming to this decision the Committee considered the respondent’s application to adjourn this inquiry in the light of the evidence he adduced. It had regard to the interests of justice, the public interest in ensuring high standards are maintained by veterinary surgeons and the need to ensure the protection of animals and their welfare."
Should Mr Staton seek to apply to rejoin the Register then the proceedings will become active again and a Disciplinary Committee hearing will be scheduled.
As part of the partnership between the two companies, anyone who takes part in one of Improve's CPD courses in 2018 will be entitled to 6 months' half-price pet insurance from Agria.
Online Bitesize CPD modules cover topics including: cardiology, ophthalmology, small animal medicine, feline medicine and exotic animals. Modules are 20, 40 or 60 minutes in length and provide veterinary professionals with interactive experiences which count toward annual CPD requirements in short convenient bursts, earning digital badges and certificates to demonstrate total CPD achieved.
Nick White, Head of Veterinary Channel at Agria, said: "We’re delighted that our partnership with Improve International will give veterinary professionals free, instant access to high-quality and engaging CPD. Not only are the modules available varied and highly relevant, the 'bitesize' nature of the training makes it extremely convenient for busy practice staff to access.
"This is a great incentive for any practices not yet working with Agria to get onboard. As well as benefitting from free CPD, practices will also be working with a specialist lifetime insurer offering 5 weeks free insurance policies and much more for clients and their pets."
For more information, contact your Agria Business Development Manager or visit: www.agriapet.co.uk/bitesize and complete the Contact Us section, using 'FREE CPD' in the subject line of the enquiry box.
Ines, who graduated from the University of Santiago de Compostela in Spain in 2001, has spent the last seven years working at universities in America, Australia and Europe. She undertook her PhD in MR spectroscopy of the brain in dogs at the University of Bern-Zurich in Switzerland. She has a Masters in Radiology from University of Glasgow. She has also worked at the University of Illinois and Sydney University.
Willows clinical director Toby Gemmill said: "Ines is highly qualified and highly regarded, so is a very welcome addition to our talented imaging team. Her experience of working around the world will also be a terrific asset to the practice."
Ines said: "I am very happy and honoured to be joining Willows and to now be part of such a great diagnostic imaging team. "This is a well-known centre of excellence and I’m really looking forward to helping deliver the first class care and treatment that Willows always aims to provide."
For more information, visit www.willows.uk.net.
The charges were:
On 28 September 2015 she was convicted of stealing three packets of Tramadol to the value of £45 from Milton Keynes Veterinary Group.
On 20 April 2017 she was convicted on two counts of issuing a false prescription with the intention of being dispensed Tramadol.
On 15 June 2017 she was convicted of numerous counts of making false prescriptions, as well as stealing £108.47 worth of scratch cards and cigarettes from Premier Queensway Stores.
Between 5 January 2015 and 25 August 2015 she held herself out as a registered veterinary nurse when she was in fact not on the Register, and worked at two separate veterinary practices during that time; and that she was therefore either (i) being dishonest, or (ii) ought to have known that she was not registered.
That on or around 13 April 2016, she made a written representation on an application form for restoration to the Register that she had no criminal convictions, when on 28 September 2015 she had been convicted of burglary and that conviction was not spent; and that she was (i) either dishonest, or (ii) ought to have known that the representation was false.
Ms Wilde admitted charges 1-3, and the Committee were also provided with copies of the convictions. The Committee therefore found charges 1-3 proven.
In considering the fourth charge, they took into account Ms Wilde’s submission that she believed the submission of a cheque would be enough to restore her to the Register. The Committee noted that she had restored herself to the Register in the past, however, and so would have been aware that a cheque alone was not sufficient, and she had also been sent a restoration form following a telephone call with the College on 2 January 2015. The Committee therefore found that Ms Wilde was being dishonest, and determined that charge 4(i) was proven.
In considering the fifth charge, the Committee considered Ms Wilde’s submission that a Probation Officer had told her that her conviction was spent and that she need not declare it. The Committee believed this to be highly unlikely, however, especially as Ms Wilde had provided no evidence from the probation service to support this assertion. The Committee therefore found her to be dishonest, and charge 5(i) to be proven.
The question of whether the facts amounted to serious professional misconduct was, however, solely a matter for the Committee’s judgement. It determined that Ms Wilde’s conduct in relation to charges 1-3 had fallen far short of the standard expected of an RVN and her conduct clearly renders her unfit to practise as an RVN.
Similarly, the Committee found that Ms Wilde’s conduct had fallen far short of the standard expected of an RVN in respect of charges 4-5, and found her conduct clearly amounted to disgraceful conduct in a professional respect.
The Committee then turned to the question of sanction, firstly in respect of charges 1-3. It considered some testimonials that spoke on Ms Wilde’s behalf, but noted that they were all unsigned and none made any reference to the charges against her. The Committee also bore in mind that Ms Wilde had no previous disciplinary history and was apologetic and remorseful, and that no harm had come to animals or humans by her actions.
It also considered, however, that her behaviour had been repeated and sustained, that she had used her knowledge as an RVN to forge prescriptions, and that she had breached the trust of her employers by stealing from them. The Committee therefore decided that removal from the Register was the only appropriate sanction.
When considering sanction in respect of charges 4-5, the Committee took into account that Ms Wilde had difficult personal circumstances and was sincerely apologetic. Using her title of RVN to gain employment when she was not on the Register, however, and breaching the trust of the College by making a false declaration, were considered serious aggravating features. It therefore considered that removal from the Register was again the only appropriate sanction.
Judith Way, who chaired the Committee and spoke on its behalf, said: “Ms Wilde’s criminal behaviour failed to maintain public confidence in the veterinary nursing profession and it failed to declare and uphold proper standards of conduct and behaviour.
“She also knew that she was not registered as an RVN, yet she held herself out as being so and obtained employment in that capacity. In holding herself out in this manner she potentially put her colleagues at risk. She could have compromised the practices that employed her in the capacity of an RVN as their insurance had the potential to be invalidated.
“Ms Wilde was also dishonest with the RCVS when she completed the application for restoration of registered veterinary nurses’ form by stating that she had no convictions. Following this application, Ms Wilde went on to commit the seven further offences (from December 2016 to March 2017) for which she was later convicted in the Northampton and Leicester Magistrates’ Courts. The committee considered that such conduct falls far short of the standards expected of an RVN.”
Ms Wilde may appeal the Committee’s decision within 28 days of being informed of it. If no appeal is received, the Committee’s judgment takes effect.
The Australian company, which launched in the UK offering equine specials in March 2017, says that while some human healthcare companies are authorised to supply veterinary specials under licence in the UK, it is currently the only company in the UK to have specific veterinary authorisation to manufacture sterile specials.
There are six formulations in Bova’s new small animal range with a further 23 formulations scheduled to be introduced in the first half of 2018. However, Bova says that due to advertising restrictions, only verified veterinary surgeons will be able to see its formulation list.
For more information, contact Bova Sales Manager Emma Jones on tel: 07780443731 or Victoria Dawson on 07780443738 or visit www.bova.co.uk.
The company will also be at BSAVA Congress this week on stand 817, where they will be offering the chance to win an afternoon champagne tea at the Ritz.
The webinars are presented by Dr Rachel Dean BVMS PhD MSc(EBHC) DSAM(fel) SFHEA MRCVS, Clinical Associate Professor in Feline Medicine at the School of Veterinary Medicine and Science, Nottingham and founding Director of the Centre for Evidence-Based Veterinary Medicine (pictured right).
The first webinar kicks off at 8:00pm on Tuesday 17th April, when Rachel will give an introduction to EBVM and reminder of why it is so important in practice.
The second session will follow on 24th April, when Rachel will explain how to find and evaluate evidence, and how you can use it to underpin your clinical decision-making process in practice.
In the final webinar, on Tuesday 1st May, Rachel will use a nutritional case study to demonstrate the real-world clinical application of EBVM concepts.
Lee Danks BVSc BVMS MRCVS, Royal Canin’s Scientific Affairs Manager said: "In this three-part series we hope to summarise EBVM for those unaccustomed to this approach and review how it can help improve our clinical decision-making in practice.
"By taking a step by step approach and delivering 'easily-digestible' lessons over three weeks we hope to answer as many questions vets and nurses have as possible with some highly applicable content from Rachel Dean."
For more information and to register, visit https://vetportal.royalcanin.co.uk/cpd/webinar2018/
The Codes of Professional Conduct for both veterinary surgeons and veterinary nurses stress the need for effective communication with clients and ensuring that informed consent is obtained and documented before treatments or procedures are carried out.
At its January meeting RCVS Standards Committee approved changes to chapter 11 (‘Communication and consent’) of the supporting guidance to the Codes to provide further advice to the professions on matters that should be discussed with clients to ensure informed consent is gained, provide clarification on who can gain consent for a procedure and give some additional guidance on consent forms.
Nick Oldham, Standards and Advisory Manager at the RCVS, said: "We hope that this updated guidance is more accessible, readable and will aid members of the profession in developing a more comprehensive approach to gaining informed consent for treatments and procedures and therefore reduce the risk of miscommunication and misunderstanding which can lead to concerns being raised by clients.
"For example, we have updated our guidance to encourage veterinary surgeons to consider discussing a number of additional factors with a client before obtaining consent. This includes the nature, purpose and benefits of any treatment or procedures, the likely outcomes including potential risks, financial estimates, informing the client when other treatments may have available and checking that the client understands what they are agreeing to rather than assuming the client understands both the potential financial outlay and possible side effects.
"Furthermore, there is now additional guidance for veterinary surgeons on who should be seeking consent. While ordinarily it is expected that the veterinary surgeon undertaking the procedure or providing treatment is responsible for obtaining the client’s consent we know that this is not always practical.
"Therefore we clarify that the responsibility of obtaining consent can be delegated to another veterinary surgeon and, failing that, a registered veterinary nurse or student veterinary nurse could obtain consent provided that they are suitably trained, have sufficient knowledge of the proposed procedure or treatment and understand the risks involved.
"The RCVS Standards and Advice Team is also in the process of producing a series of fictional case studies based on informed consent issues encountered by the College’s Preliminary Investigation Committee which we hope will further help the profession."
The updated supporting guidance can be found in full at www.rcvs.org.uk/consent
The Code of Professional Conduct and its supporting guidance can also be downloaded as an app for smartphones and tablets at www.rcvs.org.uk/codeapp
Members of the profession seeking confidential advice on matters relating to professional conduct can contact the Standards and Advice Team on 020 7202 0789 or advice@rcvs.org.uk
Ziapam is licensed for the short-term control of convulsive disorders and muscle spasms of central and peripheral origin, and for use as part of a sedation or pre-anaesthetic protocol. It is presented in packs containing 6 x 2ml vials.
Simon Boulton MRCVS, marketing manager at TVM said: "As a scheduled intravenous drug it is important that we have batch traceability and the proper monitoring of any side effects of such drugs to make sure current guidelines for use in the SPC are correct. Ziapam is kept at the same concentration of the previously used human generics on the cascade for ease of transition."
Simon added: "Furthermore, we’ve purposefully priced Ziapam such that it is only costs a few pence per dose more than the human generic."
TVM UK has also produced a dosing guide for practices which illustrates the different indications and associated treatment guidelines.
For a copy of the dosing guide or for more information, contact your local Territory Manager, email: help@tvm-uk.com, or call: 01737 781 416.
The new briefing will summarise the latest veterinary innovations, resources and research which are of practical value to those working in practice. In other words, only what you strictly need to know.
Need to Know content will be curated by three practising veterinary surgeons: Liz Barton MRCVS (Small Animal, pictured right), Aoife Byrne MRCVS (Equine), and Rachel Tennant MRCVS (Farm Animal). It replaces InDigestion, VetNurse.co.uk’s previous monthly newsletter which only linked to the most popular content on the site itself. By contrast, Need to Know summarises developments from all sources.
VetNurse.co.uk Editor Arlo Guthrie said: "In these days of information overload, our aim here is to provide busy veterinary nurses with a really succinct summary of anything that really matters, wherever it comes from."
Need to Know is the result of a new partnership between VetNurse.co.uk and Vetsnet, a veterinary wellbeing resource hub set up by Liz to support her colleagues in the profession, and the bulk of any additional advertising revenue generated by the initiative will be ploughed back into Vetsnet.
Arlo added: "Since VetNurse launched back in 2000, content has been entirely curated by me. I like to think that has worked reasonably well. Still, having practising veterinary surgeons involved editorially is a big step forward in making sure our content is always useful and relevant."
Anyone subscribed to receive emails from VetNurse.co.uk on registration will automatically receive Need To Know.
If you have subscribed, but are NOT receiving emails from VetNurse.co.uk, you usually need to log into your email account online and move emails from VetNurse.co.uk from your spam or junk folder into your inbox. Some email providers (notably Hotmail) also allow you to 'whitelist' emails from certain people and organisations. In that case, add 'vetnurse.co.uk' to your whitelist.
If you have unsubscribed from emails from vetnurse.co.uk in the past and now want to resubscribe, email support@vetnurse.co.uk and we’ll remove you from the exclusion list.
Idexx says the new test is proven to identify kidney disease earlier than creatinine1–3, enabling veterinary surgeons to intervene earlier and have a greater impact on patients' health outcomes and quality of life.
The Catalyst SDMA Test was first launched at the company's reference laboratories in 2015, since when Idexx says it has run more than 14 million SDMA patient tests, creating the world's largest database on kidney disease in dogs and cats.
The test was then launched to veterinary practices in the USA and Canada last December, where Idexx says it has now been used by thousands of practices.
Jonathan Ayers, Chairman and Chief Executive Officer of Idexx Laboratories said: "We've seen great enthusiasm for the ability to run SDMA as part of the routine chemistry panel at the point of care, and the North American launch has exceeded our expectations.
"The Idexx SDMA Test represents one of the most significant diagnostic innovations in veterinary medicine in the last 30 years. We're thrilled to bring this essential element of the chemistry panel to our point of care Idexx VetLab suite, allowing veterinarians to utilize the benefits of SDMA immediately during the pet's appointment."
Idexx has also signed an agreement to collaborate with Yale University to explore the test's applications in human health. As a result of the partnership, the SDMA Test has been validated for accuracy in measuring SDMA in human blood samples and the results presented at the 2017 annual meeting of the American Society of Nephrology last November by Yale and IDEXX researchers.
Jonathan added: "SDMA has tremendous potential benefit in human applications as well. And with the Idexx test technology now validated to be able to run on commercial chemistry systems that routinely produce chemistry results in human reference laboratories, we have greater reason to explore the clinical value of this incredible biomarker in human applications. We are excited and grateful for our partnership with Yale University."
Idexx says SDMA is now the subject of more than 30 ongoing research collaborations and has been incorporated into the veterinary profession's International Renal Interest Society (IRIS) kidney disease staging guidelines.
For more information about the IDEXX Catalyst SDMA Test, visit www.idexx.eu/sdma.
References
With at least 65% of dogs and 39% of cats reported as overweight (1&2), the competition is designed to promote a healthy body shape for cats and dogs, and reward the hard work of pet owners and veterinary nurses for achieving and maintaining a pet’s healthy weight. It is open to patients that are starting out on a weight loss programme, those maintaining a healthy body shape following weight loss and even those who have always been a healthy weight and shape.
Six finalists will be selected from all the entries and invited to attend an awards lunch where the overall winner will be announced. All finalists will receive a £100 shopping voucher and the overall winner will receive a £1000 holiday voucher.
Caroline Burke, Weight Management Specialist at Royal Canin said: "The Healthy Weight Competition is the perfect opportunity for veterinary nurses and owners to tackle this serious disease and prevent it occurring.
"There are many health issues associated with an animal being overweight as well as affecting quality of life, longevity and the welfare of the pet. The Healthy Weight Competition is an ideal opportunity for practices to identify the overweight patients, enrol them on a weight loss programme and enter the competition. It also enables them to reward those cats and dogs who have maintained an ideal body shape and weight over a period of time."
The competition is open until 31st of August 2018.
For more information, visit: www.royalcaninhealthyweight.co.uk or contact your Veterinary Business Manager.
Reference
Medivet owns 245 veterinary practices in the UK and its rate of practice acquisition had tripled in the last 12 months.
CEO, Arnold Levy said: "The 25 strong Regional Directors Team is a key strategic line of management and support for all our existing practices, and they are central to the successful integration of our new practices into our hub and spoke model. Even though each of our Regional Directors is an experienced, qualified veterinary surgeon, it is vital that they have time, knowledge and understanding of the Medivet business and operation to confidently support their practices in line with our model, in the right way.
"With the support of the Leadership Team, we will be using these next few months to ensure this newly formed group have all the skills needed to do just that."
Arnold added: "We have taken this deliberate decision to ensure we can maintain the very highest standards of client and patient care. Where our management team and support structures are already in place we will continue with our new acquisitions program, and once our Regional Management operation is fully embedded, we will confidently continue to grow our business in a sustainable, people and patient-first way."
Vouchers for twelve months' free access to Improve's Online Bitesize CPD series will be offered to veterinary surgeons, nurses and practice managers by their Protexin Territory Manager, based on their use of products in the Protexin range.
Online Bitesize CPD offers veterinary professionals the opportunity to meet their annual CPD requirements in short bursts of learning at a time and place to suit them. Its online modules of 20, 40 and 60 minutes cover a range of clinical topics, including cardiology, ophthalmology, small animal medicine, feline medicine and exotics.
Improve says the modules have been designed to be visually engaging, highly interactive and informative to ensure that the experience is rewarding.
James Kyffin, Veterinary Director at Protexin, said: "We are thrilled to be continuing our relationship with Improve International by offering practices access to its Online Bitesize CPD. We are passionate about education and Bitesize offers a convenient, exciting way for the profession to gain access to high quality CPD."
John Douglass at Improve International added: “We hope that veterinary professionals who have not yet experienced our training will take up the opportunity created by this association with Protexin Veterinary and learn new skills with our Online Bitesize CPD service for twelve months at no cost.
"The interactive modules we have created are led by recognised experts and will help them to refresh their knowledge, learn new skills and achieve their annual CPD points quota online at any time.”
Mr Smith was convicted of conspiracy to commit a fraud in which potentially dangerous horses were drugged and then sold to unsuspecting owners, at Maidstone Crown Court in June 2016. He was given 30 months' imprisonment, which formed one of the charges heard by the Disciplinary Committee.
There were also a number of charges related to his treatment of five different animals while in practice at the Lakeview Veterinary Centre in Folkestone, Kent. The charges were:
In relation to a Clydesdale mare named Grace on 14 August 2014 he failed to perform an adequate examination and/or undertake sufficient investigation and/or take a history of her; that after his initial visit to Grace on that day he failed to respond adequately to the owner’s telephone reports that Grace had deteriorated and/or failed to improve; and, that he failed to make adequate clinical records for Grace.
Between 29 September 2014 and 31 January 2015, in relation to a Labradoodle named Holly, he failed to keep adequate clinical records.
In relation to a cat named Maisey the allegations were that he failed to examine and investigate the cat adequately, he made a diagnosis of diabetes mellitus and gave insulin to administer to the cat without first undertaking the minimum investigation required, failed to keep adequate clinical records and sent an incorrect, misleading and dishonest statement to the RCVS regarding his treatment of Maisey. All charges date between 30 October and 19 December 2014.
In relation to a cat called Comet the allegation was that between 1 April and 17 April 2015 he failed to keep adequate clinical records and failed to respond adequately and appropriately to concerns raised by the owner.
Regarding a Yorkshire Terrier with diabetes named Poppy the allegation was that in two emergency out-of-hours calls made by Poppy’s owner to Mr Smith in April 2015 regarding the dog’s condition, he failed to recommend veterinary treatment or keep adequate clinical records. Furthermore, when the owner attended the practice following the two calls and the death of Poppy, he attributed the care to another member of the practice and failed to communicate effectively with the owner.
Having heard from a number of witnesses, including Mr Smith, and having received representations from Mr Smith in relation to the above charges, the Committee found almost all of the charges proven, with the exception of those relating to Mr Smith’s alleged conversation with Poppy’s owner at the practice following her death.
The Committee then went on to consider whether the various proven charges amounted to disgraceful conduct in a professional respect and whether the conviction rendered Mr Smith unfit to practise veterinary surgery.
In relation to the clinical charges the Committee found that, both individually and cumulatively, they amounted to disgraceful conduct in a professional respect.
The Committee also determined that the conviction rendered Mr Smith unfit to practise veterinary surgery and noted that it involved prolonged dishonesty, breach of trust, disregard for animal health and welfare and a "total abrogation of Mr Smith’s professional responsibilities."
Cerys Jones, chairing the Committee and speaking on its behalf, said: "The Committee was particularly concerned because the dishonesty went to the heart of Mr Smith’s responsibilities as a veterinary surgeon. His registration as a veterinary surgeon enabled him to take part in the conspiracy, and that role involved him conducting certified examinations on animals and supplying drugs for administration to animals. Reliable and honest certification is a vital element of the veterinary surgeon’s public role."
In considering the sanction against Mr Smith the Committee looked at the clinical charges and the conviction separately.
In relation to the clinical charges the Committee found that his treatment of the animals in these cases was fundamentally incompatible with being a veterinary surgeon. The Committee therefore directed that Mr Smith’s name should be removed from the Register of Veterinary Surgeons.
The Committee said that the case demonstrated that Mr Smith’s lack of treatment or his inappropriate treatment of these animals caused harm and that in some regards, for example the writing of accurate and contemporaneous clinical notes, Mr Smith demonstrated a total disrespect for the Code of Professional Conduct.
The Committee went on to say: "Further, he deliberately lied to his regulator. He demonstrated deep-seated attitudinal issues including a misplaced belief in his own abilities and had no insight or commitment to do anything different in the future. In those circumstances the likelihood of repetition was significant in the Committee’s view."
In considering the sanction for his conviction of conspiracy to commit fraud the Committee took into account a number of aggravating factors including the premeditated nature of the conduct, the fact it was repeated over four years and the fact that harm was caused to both animals and people as a result of his actions.
Cerys Jones said: "As the decision notes, some of the riders were novices or children and as a result of their experience they lost confidence in riding a horse. As the independent veterinary surgeon Mr Smith was in a position of responsibility because he was certifying the horses as to their suitability. A particularly aggravating feature in this case is that Mr Smith had previously been removed from the Register for falsely certifying horses for export."
In relation to the conviction the Committee also directed that the Registrar remove Mr Smith from the Register.
Mr Smith has 28 days from being informed of the Committee’s decision to make an appeal against it.
The full findings can be found here.
Shockwave therapy, or Extracorporeal shockwave therapy (ESWT) to give it its full nomenclature, sends mechanical shock waves into the affected area to stimulate the natural healing process by triggering the body’s own repair mechanisms.
The therapy is being spearheaded at Willows by Kinley Smith (pictured right), an RCVS and European specialist in small animal surgery. He said: "Shockwave therapy is a whole new line of treatment and has proved a spectacular success.
"It’s an excellent technique for dealing with certain orthopaedic conditions and there’s no invasive surgery, no wound to heal and no risk of infection so it really is a win-win-win procedure.
"It is particularly effective in the treatment of ligament and tendon injuries.
"There can be immediate pain relief for the dog; after two weeks we start to see lasting benefits and in four weeks we normally see a clear improvement.
"The added bonuses are we can normally reduce any medication; the dog can enjoy more exercise plus it is not as costly as undergoing an operation.
"Surgery is still essential in some of the more acute, problematic cases but shockwave therapy has been a terrific development in helping us provide an alternative treatment in a lot of soft tissue, muscle and bone conditions."
Stewart Halperin (pictured right), the vet who founded CarefreeCredit, said: "We originally started out by helping vets provide loans to treat pets needing medical attention which wasn’t covered by insurance, allowing them to provide the care needed, while also being paid immediately, improving cash flow and reducing bad debts.
"With this new service, vets can make their services better known in their local communities, which will also boost their turnover and allow them to care for even more animals."
Practices that use CarefreeCredit are given access to an online application process that takes around five minutes, providing loans from £250 upwards for use against any veterinary bills.
A range of credit terms are available from 0% APR upwards. They are also the only company to offer loan rates based on risk, which they say means more clients are likely to be accepted for finance.
CarefreeCredit practices that want to use the PR service need to contact the company, whereupon they'll arrange for an award-winning public relations consultant to provide the support they need - free of charge.
For further information, visit: www.carefreecredit.co.uk or call 0345 313 0177.
A 2012 RVC graduate, Daniella is the Principle Exotics Vet at ParkVet Hospital and is studying towards a certificate in Zoological Medicine. She said: "Despite their amazing work, the AWF struggles for funds to continue its vital work, so I have decided not only to be the first ever person to run the London Marathon for the AWF, but to run it in costume!
"Those who know me will be aware that running is not among my favourite activities, but I am stepping up to the challenge to raise much-needed funds for this fantastic charity that’s making a real, tangible difference to animals worldwide."
"Working full time in clinical practice, including being part of an out-of-hours rota, means training must be factored in with military precision: so far, some of my longer runs are planned for 4 am!
"I also entered the Hastings Half Marathon on 18 March, and my final training run prior to the big day is scheduled for when I will be in Queensland, Australia for my brother’s wedding.
"If I can manage 22 miles in those hot and humid conditions, the London Marathon should be a breeze!”
Chris Laurence. AWF Chair of Trustees, said: "I am delighted that Daniella has chosen to raise funds for AWF in what is arguably one of the biggest sporting events in the world. On behalf of the organisation, I’d like to thank her for her support and wish her all the best for the marathon."
To support Daniella’s fundraising, visit: https://uk.virginmoneygiving.com/DaniellaDosSantos
For updates on her training and to find out more about AWF, visit www.bva-awf.org.uk
During the week, veterinary professionals, retailers and rabbit owners will be encouraged by Burgess and campaign partners the RSPCA, RAWF, Wood Green, PDSA and Blue Cross to sign and share a pledge to move away from muesli on the website: http://www.rabbitawarenessweek.co.uk.
Alex Thorne at Burgess Pet Care, said: "Muesli should never be part of a rabbit’s diet but, sadly, a widespread lack of understanding and awareness around its risks means it’s often too easy for rabbit owners to make the wrong choice. Research continues to show that there is a lack of understanding around the correct nutritional needs of rabbits, and the continued feeding of muesli is a major outcome of that.
"Feeding rabbits muesli increases the risk of selective feeding. Just like children would typically pick sweet treats when faced with the choice between them or vegetables, rabbits will eat parts of the muesli mix that are high in starch and sugar, whilst leaving behind the more nutritious elements.
"We’re encouraging all rabbit lovers to get involved with this year’s campaign by visiting the Rabbit Awareness Week website and signing the ‘Move Away from Muesli’ pledge, before spreading the word amongst fellow rabbit owners. It’s our ambition to move as many rabbits away from muesli towards a good quality hay-based diet supplemented by a small portion of high-quality nuggets and a few fresh greens, which provides the nutrients rabbits need to be happy and healthy."
Burgess says there will also be campaign packs to help support practices in spreading the word, details of which will be available nearer the time.
'Hany’s Heartbreak' was a gorily realistic representation of a dog’s heart infected with Dirofilaria Immitis, baked by vet students Anna Burrows, Caitlin Glover, Chloe Tredinnick and Liberty Daly.
It pulled in votes from all over the world including Australia and the US, Saudi Arabia, Germany, Italy and the Caribbean.
The winning bakers said: "We chose to bake this cake as we wanted to make something that we could make look as realistic as possible and as gruesome.
"Our parasitology lecturer, Hany, inspired us to use the D. Immitis parasite as our theme to promote the message of how detrimental and possibly fatal some animal parasites can be! We had a great time baking it and enjoyed the looks of disgust that people who saw it gave. We promise it tastes better than it looks! Our key message to everyone is to PLEASE WORM YOUR PETS!"
The categories for baking inspiration this year were Transport to Campus, Scrumptious Science, Blue Planet and a Showstopper section. Sir David Attenborough and Pixar characters Nemo and Dory were among the other stars of the show, with colourful cakes on an environmental theme also winning prizes.
One of this year’s judges was Dr Wendela Wapenaar, Associate Professor at the Nottingham Vet School. Wendela said: “It’s been another great year for the Sutton Bonington Bakeoff. It was impressive to see how some bakers took on the challenging topics for this year; winning cakes were covering topics such as global warming, environmental pollution in addition to the more gory aspects of veterinary medicine."
The lecture, which will take place at 4:30pm on Friday 6th April in the Premier Lounge, Arena Birmingham, is presented by Dr Ivan Crotaz BVetMed MRCVS and human anaesthesiologist Dr Muhammed Nasir MBBS BSc FFARCSI MRCA (pictured right).
Chris Geddes MRCVS, Marketing Manager for Docsinnovent, says the lecture is not to be missed for two reasons: "Firstly, the topic is very current – a lot of new information is emerging about regurgitation and reflux in our veterinary patients. We are learning that the starving times we have all been recommending for years may not be ideal after all.
"Secondly, the lecture will be presented by both a vet with an interest in airway management (Dr Crotaz) and a renowned human anaesthesiologist (Dr Nasir) – so we as a profession can learn from what is happening in the field of human medicine."
The session will include a review of the situation in human anaesthesia. The anatomy of the upper airway and oesophagus of the major small animal veterinary species will be examined as well as the pathogenesis, occurrence and disease associated with reflux.
Pre-, intra- and post-operative management will be discussed, as well as current recommendations for starving veterinary patients.
The lecture is free for BSAVA attendees to attend and will be followed by drinks and nibbles supplied by Docsinnovent, who are also exhibiting at BSAVA congress on stand 1006.
The initiative was the idea of one of the practice's client care co-ordinators, who suggested it whilst she was acting as the managing director for the day, as part of White Cross Vets' 80 year anniversary celebrations.
Managing director Tim Harrison said: "We believe we are the first veterinary practice in the UK to offer two full days paid peternity leave. Our ethos is all about caring for pets, and the first few days at home with a new addition are so special. It’s therefore essential that quality time can be dedicated to a new pet, in order to make sure they feel comfortable and safe in their new environment.
"As all of our team are all pet owners already, this time off will give them the chance to introduce and socialise any new family members with existing pets, which must be done carefully and under supervision.
"Bringing a new pet into the family takes a lot of patience and perseverance, and certain breeds or older pets can be harder to train or take longer to bond. Also there is a lot of preparation work that needs to be done in the home and garden when a young pet dog, cat or rabbit arrives, so this time off will hopefully make it easier for our team to give their new pets a safe and welcoming start in their new homes."
Other perks that White Cross Vets offers include five fully paid donation days a year to volunteer with chosen charities, a health care scheme, days off and cakes for birthdays, as well as subsidised Fitbits and gym memberships.
The manufacturer has identified that there is a potential for decreased levels of the preservative Chlorobutanol hemihydrate in the following batch: J2101-03 Expiry 11/2018.
Oxytobel is distributed in the UK by Bimeda UK. Veterinary practices that have purchased this batch number should contact Bimeda to arrange collection.
Any queries in relation to return of the product or credit for the product returned should be addressed to Kay Cowton, Bimeda UK Sales on 01248 725400 or email: uksales@bimeda.com
For further information on the recall please contact Bela-pharm GmbH & Co.KG: +49 (0) 44 41 873 294.
The aim of the study was to assess the efficacy and adverse effect profile of each individual AED by analysing all available data published and then evaluating how reliable it was.
The researchers gathered, screened and assessed all the information published in peer-reviewed journals and publications. The individual studies were then evaluated based on the quality of evidence, study design, study group sizes, subject enrolment quality and overall risk of bias, as well as the efficacy and safety outcome measures.
Lead-author, Marios Charalambous from Ghent University, said: "We recruited systematic methods to combine, compare and summarise the results of independent studies and, therefore, create more objective and reliable conclusions based on the current evidence. It was a time-consuming, demanding and challenging process, and we hope we provided the clinicians now with essential information which they can use for daily practice."
The researchers found that much of the evidence for the medical treatment of feline epilepsy was based on below-par reporting of efficacy and adverse effect, worse than what was formerly reported in dogs.
The lack of good quality evidence led authors to conclude that it would be: "...rather inaccurate to make definite statements on which one [AED] should be considered as a first or second choice in terms of both efficacy and safety profile. However, if clinicians focus on AED’s efficacy, phenobarbital can be used as first-choice monotherapy and if they focus on AED’s safety, imepitoin or levetiracetam can be used."
Holger Volk, Head of the Department Clinical Science and Services and Professor of Veterinary Neurology and Neurosurgery at the RVC, said: "Not only does this study offer a new perspective on the management of feline epilepsy, but also highlights the importance of the need for trials which provide high quality evidence in order to have more reliable and objective results about the efficacy and safety of the AEDs in feline epilepsy."
The study was published in BMC Veterinary Research (https://doi.org/10.1186/s12917-018-1386-3).